UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Solvent optimization for efficient enzymatic monoacylglycerol production based on a glycerolysis reaction

Journal of the American Oil Chemists' Society, 2005-08, Vol.82 (8), p.559-564

2005

Volltextzugriff (PDF)

M3814, a DNA-dependent Protein Kinase Inhibitor (DNA-PKi), Potentiates the Effect of Ionizing Radiation (IR) in Xenotransplanted Tumors in Nude Mice

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.940-941

2016

Volltextzugriff (PDF)

Evaluation of Binary Solvent Mixtures for Efficient Monoacylglycerol Production by Continuous Enzymatic Glycerolysis

Journal of agricultural and food chemistry, 2006-09, Vol.54 (19), p.7113-7119

2006

Volltextzugriff (PDF)

Production of Heat-Sensitive Monoacylglycerols by Enzymatic Glycerolysis in tert-Pentanol: Process Optimization by Response Surface Methodology

Journal of the American Oil Chemists' Society, 2006, Vol.83 (1), p.27-33

2006

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

Annals of oncology, 1997-12, Vol.8 (12), p.1197-1206

1997

Volltextzugriff (PDF)

The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy

Annals of oncology, 2001-06, Vol.12 (6), p.745-760

2001

Volltextzugriff (PDF)

Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family

The Journal of biological chemistry, 1994-09, Vol.269 (36), p.22817-22822

1994

Volltextzugriff (PDF)

601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

Annals of oncology, 2020-09, Vol.31, p.S501-S502

2020

Volltextzugriff (PDF)

LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study

Annals of oncology, 2022-09, Vol.33, p.S1400

2022

Volltextzugriff (PDF)

A phase Ia/Ib trial of the DNA-PK inhibitor M3814 in combination with radiotherapy (RT) in patients (pts) with advanced solid tumors: Dose-escalation results

JOURNAL OF CLINICAL ONCOLOGY, 2018, Vol.36 (15_suppl), p.2518-2518

2018

Volltextzugriff (PDF)

Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis

British Journal of Cancer, 1999-06, Vol.80 (7), p.1012-1019

1999

Volltextzugriff (PDF)

Pimasertib (Pim) and Sar245409 (Sar) - a Mek and Pi3K/Mtor Inhibitor Combination: a Phase Ib Trial with Expansions in Selected Genotype-Defined Solid Tumors

Annals of oncology, 2014-09, Vol.25, p.iv146

2014

Volltextzugriff (PDF)

443OPIMASERTIB (PIM) AND SAR245409 (SAR) - A MEK AND PI3K/MTOR INHIBITOR COMBINATION: A PHASE IB TRIAL WITH EXPANSIONS IN SELECTED GENOTYPE-DEFINED SOLID TUMORS

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv146-iv147

2014

Volltextzugriff (PDF)

Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line

British journal of cancer, 2001-10, Vol.85 (8), p.1211-1218

2001

Volltextzugriff (PDF)

In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor

British journal of cancer, 1998-09, Vol.78 (5), p.631-640

1998

Volltextzugriff (PDF)

Erratum: Profile of a differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line

British journal of cancer, 2001-12, Vol.85 (12), p.2023-2025

2001

Volltextzugriff (PDF)

Expression of transforming growth factor β (TGFβ) receptors and expression of TGFβ1, TGFβ2 and TGFβ3 in human small cell lung cancer cell lines

British journal of cancer, 1993-05, Vol.67 (5), p.1015-1021

1993

Volltextzugriff (PDF)

Growth suppression by transforming growth factor β1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor

British journal of cancer, 1994-05, Vol.69 (5), p.802-808

1994

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Activation Induces Nuclear Targeting of Cyclooxygenase-2, Basolateral Release of Prostaglandins, and Mitogenesis in Polarizing Colon Cancer Cells

Proceedings of the National Academy of Sciences - PNAS, 1997-01, Vol.94 (2), p.657-662

1997

Volltextzugriff (PDF)

Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer

Lung Cancer, 1994-09, Vol.11 (3), p.153-178

1994

Volltextzugriff (PDF)

The type III epidermal growth factor receptor mutation

Annals of oncology, 2001-06, Vol.12 (6), p.745-760

2001

Volltextzugriff (PDF)

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines

British journal of cancer, 1993-05, Vol.67 (5), p.1015-1021

1993

Volltextzugriff (PDF)

Analysis of the epidermal growth factor receptor specific transcriptome: Effect of receptor expression level and an activating mutation

Journal of cellular biochemistry, 2005-10, Vol.96 (2), p.412-427

2005

Volltextzugriff (PDF)

Double blind, placebo-controlled randomized study of chlorhexidine prophylaxis for chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.8508-8508

2006

Volltextzugriff (PDF)

Enzymatic synthesis of designer lipids

Oléagineux corps gras lipides, 2008-05, Vol.15 (3), p.189-195

2008

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(46)
Dänisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Solvent optimization for efficient enzymatic monoacylglycerol production based on a glycerolysis reaction

M3814, a DNA-dependent Protein Kinase Inhibitor (DNA-PKi), Potentiates the Effect of Ionizing Radiation (IR) in Xenotransplanted Tumors in Nude Mice

Evaluation of Binary Solvent Mixtures for Efficient Monoacylglycerol Production by Continuous Enzymatic Glycerolysis

Production of Heat-Sensitive Monoacylglycerols by Enzymatic Glycerolysis in tert-Pentanol: Process Optimization by Response Surface Methodology

Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials

The type III epidermal growth factor receptor mutation. Biological significance and potential target for anti-cancer therapy

Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family

601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours

LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study

A phase Ia/Ib trial of the DNA-PK inhibitor M3814 in combination with radiotherapy (RT) in patients (pts) with advanced solid tumors: Dose-escalation results

Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis

Pimasertib (Pim) and Sar245409 (Sar) - a Mek and Pi3K/Mtor Inhibitor Combination: a Phase Ib Trial with Expansions in Selected Genotype-Defined Solid Tumors

443OPIMASERTIB (PIM) AND SAR245409 (SAR) - A MEK AND PI3K/MTOR INHIBITOR COMBINATION: A PHASE IB TRIAL WITH EXPANSIONS IN SELECTED GENOTYPE-DEFINED SOLID TUMORS

Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line

In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor

Erratum: Profile of a differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line

Expression of transforming growth factor β (TGFβ) receptors and expression of TGFβ1, TGFβ2 and TGFβ3 in human small cell lung cancer cell lines

Growth suppression by transforming growth factor β1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor

Epidermal Growth Factor Receptor Activation Induces Nuclear Targeting of Cyclooxygenase-2, Basolateral Release of Prostaglandins, and Mitogenesis in Polarizing Colon Cancer Cells

Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer

The type III epidermal growth factor receptor mutation

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines

Analysis of the epidermal growth factor receptor specific transcriptome: Effect of receptor expression level and an activating mutation

Double blind, placebo-controlled randomized study of chlorhexidine prophylaxis for chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy)

Enzymatic synthesis of designer lipids

Suchergebnisse filtern